Relationship between Vitamin D Receptor gene polymorphisms and the components of metabolic syndrome

Nutrition Journal

Volumn 12, Issue 1, 2013, Pages

  Schuch, Natielen Jacques ^a   Garcia, Vivian Cristina ^a   Vívolo, Sandra Roberta Gouvea Ferreira ^a   Martini, Lígia Araújo ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Metabolic syndrome; Parathyroid hormone; Polymorphisms; Vitamin D; Vitamin D Receptor gene

Indexed keywords

GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; TRIACYLGLYCEROL; VITAMIN D RECEPTOR;

ADULT; ALLELE; ARTICLE; CELLULAR SECRETION; CROSS-SECTIONAL STUDY; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE BLOOD LEVEL; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; INSULIN RELEASE; INSULIN RESISTANCE; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PARATHYROID HORMONE BLOOD LEVEL; POLYMERASE CHAIN REACTION; TRIACYLGLYCEROL BLOOD LEVEL; VITAMIN BLOOD LEVEL;

ADULT; AGED; ALLELES; ANTHROPOMETRY; BLOOD GLUCOSE; BLOOD PRESSURE; BRAZIL; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; SOCIOECONOMIC FACTORS; TRIGLYCERIDES; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84880128373     PISSN: None     EISSN: 14752891     Source Type: Journal    
DOI: 10.1186/1475-2891-12-96     Document Type: Article

References (43)

1. The vitamin D story: a collaborative effort of basic science and clinical medicine. DeLuca HF, FASEB J 1988 2 224 236 3280376
2. The role of the vitamin D endocrine system in health and disease. Reichel H, Koeffler HP, Norman AW, N Engl J Med 1989 320 980 991 10.1056/ NEJM198904133201506 2648151 (Pubitemid 19101616)
3. Concentrations of serum vitamin D and the metabolic syndrome among U.S. adults. Ford ES, Ajani UA, McGuire LC, Liu S, Diabetes Care 2005 28 1228 1230 10.2337/diacare.28.5.1228 15855599 (Pubitemid 40616645)
4. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Chiu KC, Chu A, Go VL, Saad MF, Am J Clin Nutr 2004 79 820 825 15113720 (Pubitemid 41103882)
5. Predicted 25-hydroxyvitamin D score and change in fasting plasma glucose in the Framingham offspring study. Liu E, McKeown NM, Pittas AG, Meigs JB, Economos CD, Booth SL, Jacques PF, Eur J Clin Nutr 2012 66 139 141 10.1038/ejcn.2011.181 22009071
6. The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. Chiu KC, Chuang LM, Yoon C, BMC Med Genet 2001 2 2 11231880
7. Evidence for alteration of the vitamin D-endocrine system in obese subjects. Bell NH, Epstein S, Greene A, Shary J, Oexmann MJ, Shaw S, J Clin Invest 1985 76 370 373 10.1172/JCI111971 2991340 (Pubitemid 15243466)
8. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey. Martins D, Wolf M, Pan D, Zadshir A, Tareen N, Thadhani R, Felsenfeld A, Levine B, Mehrotra R, Norris K, Arch Intern Med 2007 167 1159 1165 10.1001/archinte.167.11.1159 17563024 (Pubitemid 46919818)
9. High prevalence of hypovitaminosis D in female type 2 diabetic population. Isaia G, Giorgino R, Adami S, Diabetes Care 2001 24 1496 10.2337/diacare.24.8.1496 11473093
10. Serum 25-hydroxyvitamin D3 levels decreased in impaired glucose tolerance and diabetes mellitus. Scragg R, Holdaway I, Singh V, Metcalf P, Baker J, Dryson E, Diabetes Res Clin Pract 1995 27 181 188 10.1016/0168-8227(95)01040-K 7555599
11. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Forman JP, Giovannucci E, Holmes MD, Bischoff-Ferrari HA, Tworoger SS, Willett WC, Curhan GC, Hypertension 2007 49 1063 1069 10.1161/HYPERTENSIONAHA.107.087288 17372031 (Pubitemid 351664326)
12. Non-alcoholic fatty liver disease as an independent manifestation of the metabolic syndrome: Results of a US national survey in three ethnic groups. Smits MM, Iannou GN, Boyko EJ, Utzschneider KM, J Gastroenterol Hepatol 2013 28 664 70 10.1111/jgh.12106 23286209
13. Low 25-hydroxyvitamin D level is independently associated with non-alcoholic fatty liver disease. Jablonski KL, Jovanovich A, Holmen J, Targher G, McFann K, Kendrick J, Chonchol M, Nutr Metab Cardiovasc Dis 2013 10.1016/jnumecd.2012.12.006 [Epub ahead of print]
14. Relationship between vitamin D receptor BsmI and FokI polymorphisms and anthropometric and biochemical parameters describing metabolic syndrome. Filus A, Trzmiel A, Kuliczkowska-Plaksej J, Tworowska U, Jedrzejuk D, Milewicz A, Medras M, Aging Male 2008 11 134 139 10.1080/13685530802273426 18821289
15. The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Ortlepp JR, Lauscher J, Hoffmann R, Hanrath P, Joost HG, Diabet Med 2001 18 842 845 11678976 (Pubitemid 32953792)
16. Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, et al. Diabetes 2002 51 2294 2300 10.2337/diabetes.51.7.2294 12086963 (Pubitemid 34729038)
17. The polymorphic N terminus in human vitamin D receptor isoforms influences transcriptional activity by modulating interaction with transcription factors IIB. Jurutka PW, Pemus LS, Whitifield GK, et al. Mol Endocrinol 2000 14 401 402 10.1210/me.14.3.401 10707958 (Pubitemid 32260532)
18. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B, Diabetes Care 2007 30 980 986 10.2337/dc06-1994 17277040 (Pubitemid 46556596)
19. Vitamin D receptor gene polymorphisms are associated with obesity in type 2 diabetic subjects with early age of onset. Ye WZ, Reis AF, Dubois-Laforgue D, Bellanne-Chantelot C, Timsit J, Velho G, Eur J Endocrinol 2001 145 181 186 10.1530/eje.0.1450181 11454514 (Pubitemid 32707604)
20. Association between vitamin D receptor polymorphism and type 2 diabetes or metabolic syndrome in community-dwelling older adults: the Rancho Bernardo Study. Oh JY, Barrett-Connor E, Metabolism 2002 51 356 359 10.1053/meta.2002. 29969 11887173 (Pubitemid 34232638)
21. Relationship between nutrient intake and vitamin D status in osteoporotic women. Genaro PS, Pereira GA, Pinheiro MM, Szejnfeld VL, Martini LA, Int J Vitam Nutr Res 2007 77 376 381 10.1024/0300-9831.77.6.376 18622947 (Pubitemid 351954600)
22. Influence of ultraviolet radiation on the production of 25 hydroxyvitamin D in the elderly population in the city of Sao Paulo (23 degrees 34'S), Brazil. Saraiva GL, Cendoroglo MS, Ramos LR, Araujo LM, Vieira JG, Kunii I, Hayashi LF, Correa MP, Lazaretti-Castro M, Osteoporos Int 2005 16 1649 1654 10.1007/s00198-005-1895-3 15947862 (Pubitemid 41790871)
23. Prevalence of vitamin D insufficiency in brazilian adolescents. Peters BSE, Santos LC, Fisberg M, Wood RJ, Martini LA, Ann Nutr Metab 2009 54 15 21 19641346
24. High prevalence of hypovitaminosis D and secondary hyperparathyroidism in elders living in nonprofit homes in South Brazil. Scalco R, Premaor MO, Froehlich PE, Furlanetto TW, Endocrine 2008 33 95 100 10.1007/s12020-008-9061-2 18401764
25. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Wang TJ, Zhang F, Ricahrds JB, Kestenbaum B, van Meurs JB, Berry D, Kiel D, Streeten EA, Ohlsson C, Koller DL, et al. Lancet 2012 376 180 188
26. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, et al. Circulation 2005 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
27. Homeostasis model assessment: insulin resistance and B-cell function from fasting plasma glucose and insulin concentrations in man. Mattheus D, Hosjer J, Rudenski A, Naylor B, Treacher D, Turner R, Diabetologia 1985 28 421 419
28. A simple salting out procedure for extracting DNA from human nucleated cells. Miller SA, Dykes DD, Polesky HF, Nucleic Acids Res 1988 16 1215 10.1093/nar/16.3.1215 3344216
29. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF, Nucleic Acids Res 1989 17 2503 2516 10.1093/nar/17.7.2503 2785681 (Pubitemid 19103235)
30. Vitamin D deficiency inhibits pancreatic secretion of insulin. Norman AW, Frankel JB, Heldt AM, Grodsky GM, Science 1980 209 823 825 10.1126/science. 6250216 6250216 (Pubitemid 10017495)
31. 1,25-Dihydroxyvitamin D3 and pancreatic beta-cell function: vitamin D receptors, gene expression, and insulin secretion. Lee S, Clark SA, Gill RK, Christakos S, Endocrinology 1994 134 1602 1610 10.1210/en.134.4.1602 8137721
32. Rapid normalization/stimulation by 1,25-dihydroxyvitamin D3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Cade C, Norman AW, Endocrinology 1987 120 1490 1497 10.1210/endo-120-4-1490 3549262 (Pubitemid 17054005)
33. Influx of extracellular calcium mediates 1,25-dihydroxyvitamin D3-dependent transcaltachia (the rapid stimulation of duodenal Ca2+ transport). de Boland AR, Norman AW, Endocrinology 1990 127 2475 2480 10.1210/endo-127-5- 2475 2121464 (Pubitemid 20381785)
34. The vitamin D endocrine system: identification of another piece of the puzzle. Norman AW, Endocrinology 1994 134 1601A 1601C 8137720 (Pubitemid 24110712)
35. 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line. Sergeev IN, Rhoten WB, Endocrinology 1995 136 2852 2861 10.1210/en.136.7.2852 7789310
36. Vitamin D receptor gene polymorphisms and association with type 2 diabetes mellitus in a Polish population. Malecki MT, Frey J, Moczulski D, Klupa T, Kozek E, Sieradzki J, Exp Clin Endocrinol Diabetes 2003 111 505 509 14714273 (Pubitemid 38101497)
37. Serum cholesterol and expression of ApoAI, LXRbeta and SREBP2 in vitamin D receptor knock-out mice. Wang JH, Keisala T, Solakivi T, Minasyan A, Kalueff AV, Tuohimaa P, J Steroid Biochem Mol Biol 2009 113 222 226 10.1016/j.jsbmb. 2009.01.003 19429425
38. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Kim DH, Sabour S, Sagar UN, Adams S, Whellan DJ, Am J Cardiol 2008 102 1540 1544 10.1016/j.amjcard.2008.06.067 19026311
39. Regulation of adiposity by dietary calcium. Zemel MB, Shi H, Greer B, Dirienzo D, Zemel PC, FASEB J 2000 14 1132 1138.39 10834935
40. The possible role of Ca2+ on the activation of microsomal triglyceride transfer protein in rat hepatocytes. Cho HJ, Kang HC, Choi SA, Ju YC, Lee HS, Park HJ, Biol Pharm Bull 2005 28 8 1418 1423 10.1248/bpb.28.1418 16079486 (Pubitemid 41379692)
41. Insulin sensitivity in subjects with secondary hyperparathyroidism and the effect of a low serum 25-hydroxyvitamin D level on insulin sensitivity. Kamycheva E, Jorde R, Figenschau Y, Haug E, J Endocrinol Invest 2007 30 126 132 17392602 (Pubitemid 46614443)
42. The role of vitamin D for bone health and fracture prevention. Holick MF, Curr Osteoporos Rep 2006 4 3 96 102 10.1007/s11914-996-0028-z 16907998 (Pubitemid 44623931)
43. Vitamin D-effects on skeletal and extraskeletal health and the need for supplementation. Wacker M, Holick MF, Nutrients 2013 5 1 111 48 10.3390/nu5010111 23306192